The first pill to treat adults with severe alopecia was approved by the U.S. Food and Drug Administration on Monday. Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot, the agency said in a news release announcing the approval. “Access to safe and effective treatment options…  read on >  read on >

Despite worries that COVID-19 symptoms can return after patients take the drug Paxlovid, such cases of rebound symptoms are actually rare, a new study shows. In an advisory last month, the U.S. Centers for Disease Control and Prevention cautioned that COVID-19 can sometimes make a comeback after an infected person has gone through a round…  read on >  read on >

Bouncing on a trampoline is always risky, but kids are more likely to suffer serious injuries at a trampoline center than at home, according to researchers who are calling for mandatory safety standards at the centers. U.S. emergency departments treat nearly 100,000 children a year for trampoline injuries. The popularity of trampoline centers has soared…  read on >  read on >

Called “forever chemicals” because they linger in the environment, new research suggests that middle-aged women with high levels of perfluoroalkyls and polyfluoroalkyls (PFAS) in their blood may be more vulnerable to high blood pressure. In the study, women aged 45 to 56 who had the highest concentrations of seven of these chemicals were 71% more…  read on >  read on >

New research gives new meaning to the term “hotheaded” — your normal brain temperature is higher and varies much more than previously thought. The findings could lead to future research into whether disruption of daily brain temperature rhythms might trigger dementia and other brain diseases, the study authors said. The researchers conducted brain scans on…  read on >  read on >

Many who suffer vaping-related lung damage will have long-term health problems lasting at least a year, a new study reports. A substantial proportion of patients continue to be wracked with breathing difficulty, brain fog and mood disorders a year after their initial diagnosis with EVALI (E-Cigarette or Vaping Use-Associated Lung Injury), according to researchers at…  read on >  read on >